https://wikimd.org/index.php?action=history&feed=atom&title=4-Hydroxycoumarins4-Hydroxycoumarins - Revision history2026-04-25T23:55:35ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.org/index.php?title=4-Hydroxycoumarins&diff=5636742&oldid=prevPrab: CSV import2024-04-20T00:01:12Z<p>CSV import</p>
<p><b>New page</b></p><div>[[File:Rattenvergifwaarschuwing_edit.JPG|Rattenvergifwaarschuwing edit|thumb]] [[File:K1_vitamin_Mechanism_of_Action.svg|K1 vitamin Mechanism of Action|thumb|left]] [[File:Cumarin2.svg|Cumarin2|thumb|left]] [[File:4-HC_Struktur.svg|4-HC Struktur|thumb]] [[File:Dicumarol.svg|Dicumarol|thumb]] '''4-Hydroxycoumarins''' are a class of [[organic compound]]s which are formally derived from [[coumarin]] by the substitution of a [[hydroxyl group]] at the 4-position. They are important in the field of [[organic chemistry]] and [[pharmacology]], serving as the core structure for several anticoagulant drugs, including [[warfarin]], [[phenprocoumon]], and [[acenocoumarol]]. These compounds play a crucial role in the prevention and treatment of thromboembolic diseases.<br />
<br />
==Chemistry==<br />
4-Hydroxycoumarins are characterized by their unique structure, which includes a benzopyrone ring system. This structure is responsible for their biological activity and their utility in drug design. The synthesis of 4-hydroxycoumarins typically involves the Pechmann condensation reaction, which combines a phenol with a β-ketoester in the presence of an acid catalyst to form the coumarin core.<br />
<br />
==Pharmacology==<br />
The pharmacological importance of 4-Hydroxycoumarins lies in their ability to act as [[Vitamin K epoxide reductase]] inhibitors. This action interferes with the vitamin K cycle, which is essential for the post-translational modification of certain proteins required for blood coagulation. By inhibiting this enzyme, 4-Hydroxycoumarins reduce the synthesis of active clotting factors, thereby exerting an anticoagulant effect.<br />
<br />
==Clinical Use==<br />
4-Hydroxycoumarins, especially warfarin, are widely used in the prevention and treatment of various thromboembolic conditions, such as [[deep vein thrombosis]] (DVT), [[pulmonary embolism]] (PE), and the prevention of stroke in patients with atrial fibrillation. Their use requires careful monitoring of the [[International Normalized Ratio]] (INR) to ensure therapeutic efficacy while minimizing the risk of bleeding.<br />
<br />
==Safety and Monitoring==<br />
The therapeutic window of 4-Hydroxycoumarins is narrow, meaning that there is a fine balance between effective anticoagulation and the risk of bleeding. Patients on these medications typically undergo regular blood tests to monitor their INR levels. Factors such as diet, other medications, and illness can affect INR levels and the metabolism of 4-Hydroxycoumarins, necessitating adjustments in dosage.<br />
<br />
==Conclusion==<br />
4-Hydroxycoumarins are a vital class of compounds in medicinal chemistry, offering significant benefits in the management of thromboembolic diseases. Their development and use exemplify the importance of organic chemistry in drug discovery and the ongoing need for careful patient management to balance efficacy with safety.<br />
<br />
[[Category:Organic compounds]]<br />
[[Category:Pharmacology]]<br />
{{medicine-stub}}</div>Prab